
    
      The study was approved by the First People's Hospital of Chenzhou, Hunan, P.R. China. Consent
      was obtained from patients in their hospital course. Eighteen patients were enrolled for each
      group. In addition, Acute Physiological and Chronic Health Evaluation II (APACHE II) score
      was used to evaluate the severity and morbidity of HS patients Serial blood samples were
      collected at indicated time points on hospital admission for HS patients (0, 2, 4, 8, 24, and
      72 h following HS). Levels of HMGB1 were detected by ELISA according to the kit
      manufacturer's instructions.
    
  